載入...
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
BACKGROUND: CD20 is a B cell lineage–specific marker expressed by normal and leukemic B cells and targeted by several antibody immunotherapies. We have previously shown that the protein from a CD20 mRNA splice variant (D393-CD20) is expressed at various levels in leukemic B cells or lymphoma B cells...
Na minha lista:
發表在: | Exp Hematol Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774009/ https://ncbi.nlm.nih.gov/pubmed/26937306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0036-3 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|